Hiroyuki Sangu serves as a Corporate Director of Yokogawa Fluid Imaging Technologies and was appointed to the board of directors in April 2020. He provides a broad range of leadership support across the Yokogawa Group.
Hiroyuki has over 25 years of experience developing and marketing microscopes and imaging systems for life sciences and pharmaceutical-related applications. He was a major contributor and early advocate for the eventual acquisition of Fluid Imaging Technologies by Yokogawa in April 2020.
Prior to joining Yokogawa Fluid Imaging, Hiroyuki was at Yokogawa Electric Corporation in Kanazawa, Japan where he held leadership roles in several departments while focusing on the product planning and development of Yokogawa's confocal microscope and several other highly-regarded drug development instruments. He has filed approximately 100 microscope-related patent applications in his work with Yokogawa.
Hiroyuki holds a B.S. degree in Mechanical Engineering from the University of Tokyo and an M.S. degree in Mechanical Engineering from the University of Tokyo.